Dr. Tabriziani is well known speaker and author of many peer review and original articles who has special interest in Kidney and Pancreas Transplantation. He has completed his Medical School at Iran University of Medical Sciences (IUMS) with honors. He finished his Internal Medicine residency at St. Barnabas Hospital, Weill Cornell Medical College in New York. He continued his education with fellowship in Nephrology and Hypertension at Georgetown University in Washington, DC and later completed his fellowship in Kidney and Pancreas Transplant at University of California San Francisco (UCSF). He was appointed at the Medical director of Pancreas Transplantation at Westchester Medical Center, New York Medical college before moving to Loma Linda University in California to serve as an Assistant Professor of Medicine in Transplant division. Currently he is a Transplant Nephrology Attending at Balboa Institute of Transplantation (BIT), Balboa Nephrology Medical Group (BNMG) in San Diego, California in United states. He is a diplomate of American Board of Internal medicine (ABIM) as well as a diplomate of American Board of Nephrology. He is also an active member of American Society of Nephrology (ASN) and American society of Transplantation (AST)

Kidney and Pancreas Transplantation

Dr. Maria Dorobantu has worked as senior specialist in internal medicine and Senior specialist in cardiology during 1990-1996. She is Director of the Research Center of Excellency for the diagnosis and treatment of cardiovascular emergencies and she is Director of Hypertension Center of Excellence, European Society of Hypertension. She is Initiator and Coordinator for National Studys SEPHAR (I-III). She is reviewer for multiple journals viz., American Heart Journal, Cor et Vasa, Journal of Hypertension, PLOS ONE

Arterial Hypertension, Acute Coronary Syndrome, Heart Failure

Samer Ellahham has served as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards.Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is Certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is the recipient of SKMC Infection Prevention Award in 2011 and 2012.Dr. Ellahham is Middle East Representative of the JCI Standards Subcommittee. He is Lean Six Sigma Master Black Belted. Dr. Ellahham is certified as EFQM 2013 Model assessor and is leading EFQM Excellence Model at SKMC with great success including winning the prestigious Dubai Quality Award in 2015 and Sheikh Khalifa Excellence Golden Award in 2015. Dr. Ellahham is the Executive SKMC sponsor of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®).SKMC is the first multispecialty ACS NSQIP center outside the US.Dr.Ellahham is a Board-certified internist, cardiologist and vascular medicine senior consultant and continues to care for patients. He is currently Cleveland Clinic Staff and on the Executive Team of The Cleveland Clinic Foundation, in Abu Dhabi, UAE. He received several research awards including the DuPont Pharmaceuticals Research Award, ACCP 58th Annual Scientific Assembly, Young Investigator Award and the American Heart Association Get with the Guidelines Award. He is also a reviewer for several peer-reviewed journals.

Cardiology and Vascular Medicine

Aristotle Protopapas Msc. (DIC) FRCS (Glasg), is a Cardiothoracic Surgeon on the Specialist Register of the Unite Kingdom since 2013. He read Medicine in Athens, Greece and holds an Msc. in Surgical Technology from the Imperial College London since 2006. Mr. Protopapas is a fellow-qua-surgeon (by examination) of the Royal College of Physicians and Surgeons in Glasgow since 1998, and member of the society of Cardiothoracic Surgery in Great Britain and Ireland since 2002. Mr. Protopapas served as an Army Medical Officer for two years before embarking in a career in surgery in native Greece, Republic of South Africa, New Zealand and presently the United Kingdom. Mr.Protopapas is interested in surgical Technology, minimal access surgery and repair of chest deformities, beating-heart and computer-assisted surgery, endoscopic conduit harvesting, pulmonary resection for primary and metastatic tumours, thoracoscopy, assessment of surgical technological solutions at clinical outcome level and virtual endoscopy-augmented reality. Mr. Protopapas envisages z hybrid cardiovascular physician for the immediate future. He serves at the Editorial Boards of Interactive Cardio Vascular and Thoracic Surgery and Medical Instrumentation, and as Associate Editor of the Journal of Medicine Case Reports. Dr.Protopapas has sat at committees for healthcare commissioning and guiding of clinical evidence, and working groups of the Royal College of Surgeons of England.

Biomedical Publishing/Bibliometry Limited Access Surgery Avalanche Safety/Snowboarding Surgical Technology and Innovation

Zeliha Selamoglu is a Professor in Medical Biology department of Nigde Ömer Halisdemir University, Turkey. She earned her PhD in Biology from Inonu University, She has published over 80 peerreviewed journal articles with over 760 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine: Associate Membership and European association for cancer research. She has served as Editorial Board member for many Journals.

Tyrosine Hydroxylase (TH), stress, oxidative stress, hypertension, antioxidants, selenium, propolis, pollen, apitherapy.

Dr Sandeep Shah is a leading pioneer in the Medtech Industry and a Medical Doctor, an international Medical Technology Development Expert with sector expertise in technology transfer, regulation, clinical research, market adoption and business development. He is an expert on blood pressure measurement and haemodynamics. Sandeep is Co-Founder and CEO of Tarilian Laser Technologies and ViCardio® Ltd, which has developed an award-winning patented powerful cuffless non-invasive solution to blood pressure measurement and haemodynamics.

Departments of Cardiology and Clinical Pharmacology,blood pressure measurements and Haemodynamics,Biomedical Engineering .

Ehud Baron MD D.Sc, Ex-prof. and researcher in Technion – Israel Inst. Of Technology, Aalborg University, UC Berkeley and Stanford University. Serial entrepreneur that serves as Chairman, President/CTO in Medical device companies: X-Cardio Corp. KK, Tokyo, GoldTech Sino, HK, Concardio, Inc., Cleveland and HeartBeat Technologies, Ltd., Israel, and JV with LifeQ, SA, US, NL

Cardiology

Yochai Birnbaum has completed his MD at the age of 25 years from the Hebrew University, Jerusalem, Israel. He is the John S, Dunn Chair, Professor of Medicine at Baylor College of Medicine, Houston, Texas. He has published more than 320 papers in reputed journals and has been serving as an editorial board member of 6 Journals

Cardiology

Renata Cífková completed her medical education at Charles University in Prague and in 1986 earned a PhD in internal medicine with special emphasis on cardiology. Since 2009, she has been a Professor of Medicine with the Charles University Medical School in Prague. She has also been Head of the Center for Cardiovascular Prevention, Thomayer Hospital, Prague, Czech Republic since 2010.Prof. Cífková’s primary research interests are are epidemiology of cardiovascular risk factors, primary and secondary prevention of cardiovascular disease, and clinical studies. She has held positions as Assistant Professor in the Institute of Postgraduate Medical Education, Dept of Cardiology, Prague, Czech Republic and has also been a Postdoctoral Fellow at the Faculty of Medicine, Memorial University, St. John's, Newfoundland, Canada. In 1999, she was Honorary Visiting Professor, Mayo Clinic, Rochester, Minnesota, USA.Member of the Second, Third, Fourth and Fifth Joint Task Forces of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension on prevention of coronary heart disease in clinical practiceMember of the European Society of Cardiology Task Force on cardiovascular disease in pregnancy. Member of the ESH/ESC Task Force for Joint Guidelines for the Management of Arterial Hypertension

Arterial hypertension – epidemiology, clinical trials, target organ damage – prevention and regression | Epidemiology of atherosclerosis | Preventive cardiology | Angiology

Director endocrinology, fellowship Madigan Army Medical Center, 1976-78; director, chief medicine and program director internal medicine residency program Eisenhower Army Medical Center, 1978-81, chairman directorate of clinical investigation, 1978-81, director endocrinology fellowship program; medical consultant Tuskegee VA Hospital, Alabama, 1985—; member national high blood pressure education committee NHLBI/NIH, National Diabetes Mellitus Adv. Council, National Diabetes Adv. Board, NHLBI working Committee on Hypertension and Diabetes; chairman Sub Committee Special Population and Situations, chairman subcom., executive committee Joint National Commission Detection Evaluation and Treatment of High Blood Pressure; diabetes epidemic action council Am. Diabetes Assn; member IOM/NAS Committee Medical Evaluation Vets. Disability Compensation, 2006-08.

Diabetes,Clinical Hypertension,Endocrinology & Metabolism.

Robert J. Chilton, DO, is an Associate Professor of Medicine and Director of the Cardiac Catheterization Laboratory at the Audie Murphy VA/University of Texas Health Science Center at San Antonio. A fellow of the American College of Cardiology, American College of Physicians, American College of Osteopathic Internists, and American Heart Association, Dr. Chilton also chairs the Electrophysiology Board Examination for the American Osteopathic Association and presides over the San Antonio chapters of both the Cardiovascular Society and American Heart Association. Dr. Chilton received his Bachelor of Science degree from Philips University, Enid, Oklahoma, and his DO from the University of Osteopathic Medicine and Surgery, Des Moines, Iowa. He completed his internship at Wright-Patterson Air Force Base, Dayton, Ohio; his residency at the University of Oklahoma Health Science Center, Oklahoma City, Oklahoma; and a cardiology fellowship at the Wilford Hall United States Air Force Medical Center, San Antonio, Texas. Dr. Chilton is board certified in internal medicine, cardiovascular disease, and electrophysiology. Over the past 20 years, Dr. Chilton has authored numerous articles, book chapters, abstracts, and presentations on cardiology. He has developed educational materials and has lectured widely, garnering several awards for his academic contributions, including 1994 Outstanding Teacher from the University of Texas Health Science Center at San Antonio.

Interventional Cardiology,Cardiology,Internal Medicine

Dr. Venkat Gopalakrishnan is a Professor and Head in the Department of Pharmacology, College of Medicine in the University of Saskatchewan. His Academic Credentials includes B.Sc., Chemistry, M.Sc., Ph.D., in the University of Madras, India, His research includes Cellular and Subcellular Basis for the Vascular and Cardiac Actions of Peptides (arginine vasopressin, angiotensin II, endothelin and ghrelin). Studies involve characterization of Ca2+ signal transduction events regulated by peptides using: i) functional measurement of changes in tension responses of cardiac and vascular tissues, perfused vascular bed preparations (ii) receptor binding and receptor expression studies using primary cultures of neonatal rat cardiomyocytes, minimally passaged cultured rat vascular smooth muscle (VSM) cells and endothelial cells (EC), iii) agonist(s)-evoked changes in effector systems (measurement of IP3, cAMP, cGMP, cysteinyl leukotrienes and [Ca2+]i levels and protein kinase C activity), (iv) quantification of [Ca2+]i, changes in single cardiomyocyte, VSM cells and EC using imaging technique. The major focus is to examine the role of these peptides in both normal as well as experimental models of hypertension and diabetes mellitus

diabetes mellitus, hypertension,receptor binding and receptor expression studies,

Peter de Leeuw studied medicine at the Medical School (later: Erasmus University) in Rotterdam. After his graduation in 1974, he joined professor Willem Birkenhäger at the Zuiderziekenhuis in Rotterdam for his training in Internal Medicine. From 1975 he became involved in hypertension research and in 1978 he obtained his PhD degree for his thesis ‘Vasoregulation and renal function in essential hypertension’. Subsequently, he worked as a post-doc research fellow in the Peter Bent Brigham Hospital/Harvard Medical School under the supervision of professor Norman Hollenberg. Following several years of clinical practice in Rotterdam during which he continued his research he was appointed professor of Medicine at the University of Maastricht in 1991. Presently, he chairs the Division of Vascular Medicine at the University Hospital of Maastricht where he supervises 10 PhD students. Peter de Leeuw was President of the Dutch Society of Hypertension (1988-1996) and has served as a member of the Scientific Council of the International Society of Hypertension (1992-2000). He was and is on the Editorial Board of several journals in the field of hypertension and (general) internal medicine. Presently, he is Editor-in-Chief of the Nederlands Tijdschrift voor Geneeskunde. He has been the Chairman of the Endpoint Committee of the Syst-Eur trial and member of the Steering Committee of the INSIGHT trial. He has also been involved in the organization of several meetings, amongst others as the Secretary for the 17th Scientific Meeting of the International Society of Hypertension which took place in Amsterdam in 1998. He also was a member of several scientific committees, e.g. those of the Dutch Heart Foundation, Dutch Kidney Foundation and ZonMW.

Hypertension, Nephrology

Pieter Doevendans became a cardiologist in Maastricht. In 1993-1994 he had the opportunity to work with Ken Chien at UCSD San Diego where the work on stem cells started. The work was completed in Maastricht and provided the basis for a thesis on the promoter of the atrialMLC gene. Upon return in the Netherlands he worked with Christine Mummery and Hans Clevers (Hubrecht Laboratory). In the meantime he remained active as an interventional cardiologist initially in Maastricht, but from 2002 on in Utrecht. Here he was appointed full professor in Cardiology in 2004 and head of the department in 2005. The focus is on Cardiac Failure, stem cells and genetics. He was funded by various national and international foundations. Thus far (2016) he published more than 650 peer reviewed papers and 12 books. He is an active member of the European Society of Cardiology where he performed various tasks

Cardiovascular disease: the regulation of cardiac gene expression, signaling in cardiac hypertrophy, the genetics of cardiovascular disease and stem cells to generate cardiomyocytes, and biological pacemaking.

Louis Peeters dedicated most of his scientific career to the study of maternal physiology in pregnancy and of the pathophysiology of hypertensive pregnancy disorders, both in animals and women. He started his career in 1974 with a fellowship in Fetal & Maternal Medicine at the Un. of Colorado, Denver. After his residency in Ob/Gyn. (1976-1981, Nijmegen, the Netherlands), he worked at the Dept. of Ob/Gyn., Erasmus Univ., Rotterdam and from 1987 at the Dept of Ob/Gyn, MUMC, Maastricht. In 1987 and 2001/2002, resp., he interrupted his work in the Netherlands for sabbaticals at Columbia Univ, New York City (Dept. Physiology) and UCSF, San Francisco (Dept. Ob/Gyn.). From 2011 he worked at the Dept. Ob., UMC Utrecht, to retire from clinical duties in 2013. Afterwards he continued his work in education and research. During his career he published over 150 scientific articles and over 20 book chapters.

Physiology of pregnancy, Pregnancy and maternal diseases (hypertension, renal, cardiovascular, metabolic, and autoimmune diseases)Repeated miscarriages.

Dr. Tabriziani has earned his MD with honors from Iran University of Medical Sciences (IUMS). He finished his Internal Medicine residency at St. Barnabas Hospital, Weill Cornell Medical College in New York. With passion for education and Transplantation, he accepted the fellowship in Nephrology and Hypertension at Georgetown University in Washington, DC and continued his education at University of California San Francisco (UCSF) with a Transplant Nephrology fellowship. He was appointed at the Medical director of Pancreas Transplantation at Westchester Medical Center, New York Medical college before moving to Loma Linda University in California to serve as an Assistant Professor of Medicine in Nephrology / Transplant division. He is an active member of American Society of Nephrology and American society of Transplantation.

His interests are in Hypertension and Oxidative Stress in patients with chronic kidney disease and transplantation.

Stamatios Lerakis is a Professor of Medicine and Radiology and Imaging Sciences in the Division of Cardiology at Emory University. He is Adjunct Professor of Biomedical Engineering in Georgia Institute of Technology and Emory University. He received his M.D. degree from the Medical School of Athens (Greece) in 1988. He continued on doing clinical research in Nuclear Cardiology in Mount Sinai Medical Center in New York City. Subsequently, he did his Internal Medicine training in the Presbyterian Medical Center of Philadelphia from 1991 to 1994 and completed his Fellowship in Critical Care in Brown University from 1994 to 1995. He went on to complete his Cardiology Fellowship at the University of Texas Medical Branch in Galveston, Texas from 1995 to 1998 and then did one year of Echocardiography Fellowship at Emory University from 1998 to 1999. After his Echocardiography Fellowship, he has stayed on as Faculty in the Division of Cardiology practicing clinical and non-invasive cardiology. Dr. Lerakis’ research interests are focused on non-invasive cardiology. He is especially interested in the correlation of different non-invasive modalities in the diagnosis of Coronary Artery Disease. He is interested in Endocarditis and is the primary investigator at Emory University of the International Collaboration of Endocarditis study. He is extremely interested in the use of Echocardiography for guiding interventional procedures, device deployment and Transcatheter Valvular therapies of Structural and Valvular Heart Disease. Dr. Lerakis is the Director of Imaging for the Emory Structural and Valve Heart Center and Director, Cardiac MRI in Emory University Hospital and Emory Clinic. He is also interested in the study of Valvular Heart Disease by Echo and cardiac MRI and novel therapies for acute myocardial infarction patients. Dr. Lerakis is extremely interest in using 3D Echo for the evaluation of the cardiac anatomy and function. Dr. Lerakis attends at Emory University Hospital and Emory Clinic. He spends a lot of time teaching cardiology fellows, cardiac anesthesia fellows and radiology residents, basic and cutting edge technologies of non-invasive cardiac imaging modalities. He has received multiple teaching awards from the fellows.

Valvular Heart Disease, Echocardiography,Cardiac MRI, non-invasive cardiac imaging

Bertram Pitt received his MD degree from the University of Basel in 1959. After a residency in medicine he worked at the Walter Reed Army Medical research Institute from 1963-1966. He completed a fellowship in cardiology at the Johns Hopkins University School of Medicine and remained there on the faculty until 1977 when he joined the University Of Michigan School Of Medicine as director of the division of cardiology. He is currently professor of medicine emeritus, has published over 750 peer reviewed papers, and received life time achievement awards from the AHA and ESC-HF society.

Cardiovascular diseases, Ischemic heart disease, heart failure

Asher Kimchi, MD, is the clinical chief of the Division of Cardiology and co-medical director of the Preventive and Consultative Heart Center of Excellence at the Cedars-Sinai Heart Institute. He holds the academic title of clinical professor of Medicine. He is also a past president of the Greater Los Angeles Affiliate of the American Heart Association. Kimchi, a former flight surgeon in the Israeli Air Force, is the founder and chair of the International Academy of Cardiology. He founded the World Congress on Heart Disease and has served as its chair for 26 years. Through the organization, he has directed 22 international congresses on heart failure and heart disease. He is an editor or co-editor of 12 books, and his scientific articles on the diagnosis and treatment of coronary artery disease and heart failure have appeared in prestigious peer-reviewed journals, including Circulation, the American Journal of Cardiology, JAMA Internal Medicine and the American Heart Journal. He has presented his scientific work at numerous national and international conferences. He serves on the editorial board of the journal Cardiology.

Arrhythmias (Irregular Heartbeat, Heart Rhythm Disorders), Hypertension, Congestive Heart Failure (CHF), Coronary Artery Disease (CAD)and Preventive Cardiology

Jose Antonio F. Ramires, MD, PhD has completed his PhD at the age of 28 years from University of São Paulo Medical School, Brasil and postdoctoral studies from the same University. He was the Scientific Director, Learn Director and General Director of the Instituto do Coração-INCOR (Heart Institute) of the University of São Paulo. Actually, he is Head Professor of Cardiology of the Instituto do Coração-INCOR and coordinator of medical graduate of the INCOR. Dr. Ramires was President of the São Paulo State Cardiology Society, Brazilian Society of Cardiology and Brazilian Heart Foundation (FUNCOR) and Vice-President of the InterAmerican Cardiology Society. During five years (2005-2010) was President of the Professors and Researchers Evaluation Committee of the University of São Paulo. He has published more than 490 papers in reputed journals and has been serving as an editorial board member of repute.

Myocardial infarction, Angioplasty, Coronary artery disease and Acute myocardial infarction.